Associations among telomerase activity, p53 protein overexpression, and genetic instability in lung cancer

British Journal of Cancer

Volumn 80, Issue 3-4, 1999, Pages 453-457

  Wu, X ^a,b   Kemp, B ^a   Amos, C I ^a   Honn, S E ^a   Zhang, W ^a   Walsh, G L ^a   Spitz, M R ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Genetic instability; Lung cancer; p53; Telomerase activity

Indexed keywords

BLEOMYCIN; PROTEIN P53; TELOMERASE;

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENZYME ACTIVITY; ETHNOLOGY; FAMILY HISTORY; FEMALE; GENDER; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032935264     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690378     Document Type: Article

References (26)

1. Denissenko MF, Pao A, Tang M and Pfeifer GP (1996) Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in p53. Science 274: 430-432
2. Dosaka-Akita H, Shindoh M, Fujino M, Kinoshita I, Akie K, Katoh M and Kawakami Y (1994) Abnormal p53 expression in human lung cancer is associated with histologic subtypes and patient smoking history. Anat Pathol 102: 660-664
3. Fontanini G, Vignati S, Bigini D, Merlo GR, Ribecchini A, Angeletti CA, Basolo F, Pingitore R and Bevilacqua G (1994) Human non-small cell lung cancer: p53 protein accumulation is an early event and persists during metastatic progression. J Pathol 174: 23-31
4. Gallo O, Bianchi S, Giovannucci-Uzzielle ML, Santoro R, Lenzi S, Salimbeni C, Abbruzzese M and Alajmo E (1995) p53 oncoprotein overexpression correlates with mutagen-induced chromosome fragility in head and neck cancer patients with multiple malignancies. Br J Cancer 71: 1008-1012
5. Harley CB and Villeponteau B (1995) Telomeres and telomerase in aging and cancer. Curr Opin Genet Dev 5: 249-255
6. Hiyama K, Hiyama E, Ishioka S, Yamakido M, Inai K, Gazdar AF, Piatyszek MA and Shay JW (1995a) Telomerase activity in small-cell and non-small-cell lung cancers. J Natl Cancer Inst 87: 895-902
7. Hiyama K, Ishioka S, Shirotani Y, Inai K, Himaya E, Murakami I, Isobe T, Inamizu T and Yamakido M (1995b) Alterations in telomeric repeat length in lung cancer are associated with loss of heterozygosity in p53 and Rb. Oncogene 10: 937-944
8. Hollstein M, Sidransky D, Vogelstein B and Harris C (1991) p53 mutations in human cancer. Science 253: 49-53
9. Hsu TC (1983) Genetic instability in the human population: a working hypothesis. Herditas 98: 1-11
10. Hsu TC, Johnston DA, Cherry LM, Ramkisson D, Schantz SP, Jessup JM, Winn RJ, Shirley L and Furlong C (1989) Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int J Cancer 43: 403-409
11. Iggo R, Gotter K, Bartek K, Lane D and Harris AL (1990) Increased expression of mutant forms of p53 oncogen in primary lung cancer. Lancet 335: 675-679
12. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PLC, Coviello GM, Wright WE, Weinrich SL and Shay JW (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015
13. Kruk PA and Bohr VA (1996) Relationship between telomeric length and p53 status. Abstract. Proc Am Assoc Cancer Res 37: 560
14. Marx J (1994) New link found between p53 and DNA repair. Science 266: 1321-1322
15. Piatyszek MA, Kim NW, Weinrich SL, Hiyama K, Hiyama E, Wright WE and Shay JW (1995) Detection of telomerase activity in human cells and tumors by a telomeric repeat amplification protocol (TRAP). Methods Cell Sci 17: 1-15
16. Shay JW, Pereira-Smith OM and Wright WE (1991) A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 196: 33-39
17. Spitz MR, Fueger JJ, Beddingfield NA, Annegers JF, Hsu TC, Newell GR and Schante SP (1989) Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res 49: 4626-4628
18. Spitz MR, Hoque A, Trizna Z, Schantz SP, Amos CI, King TM, Bondy ML, Hong WK and Hsu TC (1994) Mutagen sensitivity as a risk factor for second malignant tumors following upper aerodigestive tract malignancies. J Natl Cancer Inst 86: 1681-1684
19. Strom SS Wu XF, Sigurdson AJ, Hsu TC, Fueger JJ, Lopez J, Tee PG and Spitz MR (1995) Lung cancer, smoking patterns, and mutagen sensitivity in Mexican-Americans. Monogr Natl Cancer Inst 18: 29-33
20. Woolf B (1955) On estimating the relation between blood group and disease. Ann Hum Genet 19: 251-253
21. Wright WE, Pereira-Smith OM and Shay JW (1989) Reversible cellular senescence: implications for immortalization of normal human diploid fibroblasts. Mol Cell Biol 9: 3088-3092
22. Wu XF, Hsu TC, Annegers JF, Amos CI, Fueger JJ and Spitz MR (1995a) A case-control study of nonrandom distribution of bleomycin-induced chromatid breaks in lymphocytes of lung cancer patients. Cancer Res 55: 557-561
23. Wu XF, Delelos GL, Annegers FJ, Bondy ML, Honn SE, Henry B, et al (1995b) A case-control study of wood-dust exposure, mutagen sensitivity, and lung-cancer risk. Cancer Epidemiol Biomarkers Prev 4: 583-588
24. Wu XF, Hsu TC and Spitz MR (1996) Mutagen sensitivity exhibits a dose-response relationship in case-control studies. Cancer Epidemiol Biomarkers Prev 5: 577-578
25. Wynford-Thomas D, Bond JA, Wyllie FS and Jones CJ (1995) Does telomere shortening drive selection for p53 mutation in human cancer? Mol Carcinog 12:119-123
26. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Traveli S, Diesseroth AB and Mercer WE (1995) p53, independent induction of WAFI/Cip1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55: 668-674